US Stock MarketDetailed Quotes
CLDI Calidi Biotherapeutics
- 2.140
- +0.210+10.88%
Close Nov 27 16:00 ET
- 2.120
- -0.020-0.93%
Post 20:01 ET
37.48MMarket Cap-713P/E (TTM)
2.303High1.940Low1.65MVolume2.140Open1.930Pre Close3.54MTurnover12.00%Turnover RatioLossP/E (Static)17.52MShares26.30052wk High-3.65P/B29.46MFloat Cap0.73052wk Low--Dividend TTM13.76MShs Float137.900Historical High--Div YieldTTM18.78%Amplitude0.730Historical Low2.145Avg Price1Lot Size
About Calidi Biotherapeutics Company
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Company Profile
SymbolCLDI
Company NameCalidi Biotherapeutics
Listing DateNov 17, 2022
Founded2014
CEOMr. Allan J. Camaisa
MarketAMEX
Employees41
Fiscal Year Ends12-31
Address4475 Executive Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-794-9600
Websitehttp://www.calidibio.com
Company Executives
- Name
- Position
- Salary
- Allan J. Camaisa
- Chief Executive Officer and Chairman of the Board
- 436.51K
- Andrew C. Jackson
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Boris Radoslavov Minev, M.D.,PhD
- President of Medical and Scientific Affairs and Interim Chief Medical Officer
- 400.10K
- Wendy Pizarro, Esq.
- Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer and Corporate Secretary
- 295.40K
- Dr. George Peoples, F.A.C.S.,Jr,M.D.
- Director
- --
- Scott Leftwich
- Independent Director
- 179.89K
- Alan R. Stewart
- Independent Director
- 120.56K
- James A. Schoeneck
- Independent Director
- 109.56K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
